Ovarian Androgen Production

“Ovarian androgen production” describes the process by which theca cells in the ovary synthesize androgen precursors (mainly androstenedione and testosterone) in response to luteinizing hormone (LH)[1][2][3][4]. These androgens serve as precursors for granulosa cell estrogen synthesis and also have direct effects on follicle maturation, ovulation, and atresia. Androgens exert their actions mainly through the androgen receptor (AR), and disruption of normal androgen production (either deficiency or excess) is centrally implicated in disorders such as polycystic ovary syndrome (PCOS) and female infertility[1][2][3][4]. The process is not a discrete, single molecular target but rather a core endocrine function involving multiple enzymes and regulatory factors within the ovarian stroma. For structured database and therapeutic targeting purposes, it is more accurate to focus on specific enzymes of androgen biosynthesis (e.g., "Cytochrome P450 17A1" or "Androgen receptor") or cell types (e.g., "Ovarian theca cell androgen production") rather than the generic function "Ovarian androgen production."[2][3][4].

Other names

Ovarian steroidogenesisOvarian androgen biosynthesisOvarian androgen pathwayAndrogen synthesis in the ovary

Enzyme inhibition (e.g., CYP17A1 inhibitors block androgen biosynthesis); Androgen receptor antagonism (e.g., block androgen action in target tissues)